Loading...

Rapidly fatal advanced EGFR-mutated lung cancers and the need for rapid tumor genotyping in clinical practice

Use of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is associated with dramatic, durable, and tolerable responses and side effect profiles when applied for palliation of advanced EGFR-mutated non-small-cell lung cancers (NSCLCs). Expert guidelines recommend that EGFR mut...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cancer Treat Commun
Main Authors: Rangachari, Deepa, Drake, Lauren, Huberman, Mark S., McDonald, Danielle C., VanderLaan, Paul A., Folch, Erik, Costa, Daniel B.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241076/
https://ncbi.nlm.nih.gov/pubmed/28111612
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ctarc.2016.07.001
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!